SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-065503
Filing Date
2017-12-13
Accepted
2017-12-13 18:29:37
Documents
2
Period of Report
2017-12-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2180
2 POA DOCUMENT poa.txt EX-24.3_756807 3819
  Complete submission text file 0001209191-17-065503.txt   7368
Mailing Address 128 SPRING STREET, SUITE 520 LEXINGTON MA 02421
Business Address
Goldberg Mark Alan (Reporting) CIK: 0001532475 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37833 | Film No.: 171254831

Mailing Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108
Business Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108 415-638-6556
Audentes Therapeutics, Inc. (Issuer) CIK: 0001628738 (see all company filings)

IRS No.: 461606174 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)